| Dr Emily Faye Bloom, MD | |
|
436 N Bedford Dr, Suite 202, Beverly Hills, CA 90210-4310 | |
| (310) 278-8811 | |
| (310) 278-1316 |
| Full Name | Dr Emily Faye Bloom |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Location | 436 N Bedford Dr, Beverly Hills, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346469715 | NPI | - | NPPES |
| 1366569139 | Other | NPI ORGANIZATION (INC.) | |
| WG38218A | Other | PPIN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | G38218 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Emily Faye Bloom, MD 436 N Bedford Dr, Suite 202, Beverly Hills, CA 90210-4310 Ph: (310) 278-8811 | Dr Emily Faye Bloom, MD 436 N Bedford Dr, Suite 202, Beverly Hills, CA 90210-4310 Ph: (310) 278-8811 |
News Archive
The Democratic platform, which was released Tuesday, includes many health care policy references, but it is light on specifics about what health initiatives would come during a second Obama term.
Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has purchased the ANDA for clindamycin phosphate (1%) and benzoyl peroxide (5%) gel from KV Pharmaceutical for $14 million in cash at closing and a $2 million milestone payment upon the completion of a successful technical transfer. This product is the AB-rated equivalent to Stiefel Laboratories' (a subsidiary of Glaxo SmithKline) Duac(R) gel, indicated for the topical treatment of inflammatory acne vulgaris.
Alzheimer's is a neurodegenerative disease that features the accumulation of the beta-amyloid peptide and Tau protein in the brain, which are associated with deficits in the neuronal connections and with dementia.
Many primary care physicians may lack the necessary knowledge when it comes to recognizing the signs, symptoms and making proper diagnoses in cases of blood cancers such as leukemia and lymphoma, a recent survey indicates.
COVID-19 patients with cardiovascular comorbidities or risk factors are more likely to develop cardiovascular complications while hospitalized, and more likely to die from COVID-19 infection, according to a new study published August 14, 2020 in the open-access journal PLOS ONE by Jolanda Sabatino of Universita degli Studi Magna Graecia di Catanzaro, Italy, and colleagues.
› Verified 6 days ago
Dr. Jeremy Cameron Davis, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8641 Wilshire Blvd Ste 115, Beverly Hills, CA 90211 Phone: 310-855-7002 Fax: 310-855-7003 | |
Dr. Peter L Kopelson, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 414 N Camden Dr, Suite 640, Beverly Hills, CA 90210 Phone: 310-271-7400 Fax: 310-271-0003 | |
Dr. Paul Wesley Wallace, MD Dermatology Medicare: May Accept Medicare Assignments Practice Location: 8920 Wilshire Blvd, Suite 327, Beverly Hills, CA 90211 Phone: 310-652-8460 Fax: 310-652-8499 | |
Dr. Edgar Franklin Fincher, MD, PHD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 421 N Rodeo Dr, Suite T-7, Beverly Hills, CA 90210 Phone: 310-274-5372 Fax: 310-274-5380 | |
Ms. Melinda Chan, PA-C Dermatology Medicare: Not Enrolled in Medicare Practice Location: 8929 Wilshire Blvd, Ph Suite 500, Beverly Hills, CA 90211 Phone: 424-256-5272 | |
Dr. Ladan Shahabi, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8641 Wilshire Blvd Ste 115, Beverly Hills, CA 90211 Phone: 310-855-7002 Fax: 310-855-7003 | |
Eric Alden Lewis, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 125 N. Robertson Blvd., Beverly Hills, CA 90211 Phone: 310-289-9700 Fax: 310-289-9779 |